by tmourit | Jan 2, 2026 | Audits, Quality, Regulatory
Artificial intelligence is reshaping nearly every function in life sciences — from drug discovery to manufacturing optimization. Yet one of the most impactful, and often overlooked, applications of AI is in quality and regulatory compliance. For MedTech and life... by tmourit | Dec 19, 2025 | Audits, Quality, Regulatory
Few phrases make quality teams more anxious than “unannounced audit.” Whether it’s a Notified Body conducting a surprise visit under the EU MDR/IVDR or an FDA investigator arriving unannounced for an inspection, these audits test your organization’s true level of... by tmourit | Dec 12, 2025 | Audits, Quality, Regulatory
For many small and growing life science manufacturers, managing quality can feel like a balancing act. On one hand, regulatory compliance is non-negotiable. On the other, budgets and staffing are often limited. Traditionally, companies have relied on paper-based... by tmourit | Dec 5, 2025 | Audits, Quality, Regulatory
Gene and cell therapies, collectively known as Advanced Therapy Medicinal Products (ATMPs), represent one of the most exciting and challenging frontiers in modern medicine. These therapies have the potential to treat, and even cure, diseases once considered... by tmourit | Nov 28, 2025 | Audits, Quality, Regulatory
Submitting a regulatory application, whether to the FDA, EMA, or another health authority, represents years of research, validation, and investment. Yet, even well-prepared companies experience delays, rejections, or major questions during the review process.... by tmourit | Nov 21, 2025 | Audits, Quality, Regulatory
Bringing a new drug or biologic to market is a long and highly regulated process — and each major region has its own regulatory authority and approval pathway. In the United States, the FDA oversees product approval. In Europe, it’s the EMA, and in Japan, it’s the...